Effectiveness and safety of dual advanced therapy in inflammatory bowel disease ? A multicenter series from Galicia, Spain
empirical use of DAT in refractory IBD may lead to clinical remission in approximately one-third of patients. Remission rates appeared more effective when DAT was used to simultaneously treat IBD and an IMID. However, further data are needed before specific recommendations can be made regarding type or timing strategy for DAT.
Authors
- Daniel Carpio (ORCID: https://orcid.org/0000-0001-7929-1151)
- Ana Echarri (ORCID: https://orcid.org/0000-0001-6690-7543)
- J Martínez Cadilla (ORCID: https://orcid.org/0000-0002-8091-9433)
- María Teresa Diz-Lois Palomares (ORCID: https://orcid.org/0000-0003-3600-8533)
- Carmen Pradera Cibreiro
- Manuel Barreiro‐de Acosta (ORCID: https://orcid.org/0000-0001-5915-1477)
- Emilio Estévez Prieto
- C. Iglesias
- Rocío Ferreiro‐Iglesias (ORCID: https://orcid.org/0000-0002-0469-4332)
Institutions
- University Hospital Complex Of Vigo (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Complejo Hospitalario de Pontevedra (ES)
Publication Details
- Journal
- Revista Española de Enfermedades Digestivas
- Published
- 2025-01-01
- DOI
- https://doi.org/10.17235/reed.2025.11430/2025
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82